Amevive alefacept regulatory update

BIIB said Israel approved Amevive to treat adults with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy. Separately, BIIB said Swissmedic issued a positive opinion letter for Amevive, and that the company is in the final stages of negotiating the labeled indication. ...